Researchers were able to restore antibiotic sensitivity by reversing pathogen resistance through a process called lysogenization. Through this process, researchers relied on bacteriophages to invade antibiotic-resistant bacteria and then isolate and engineer those cultures to reverse antibiotic sensitivity.
Proposed broad usage of lysogenization could “potentially change the nature of nosocomial infections toward being more susceptible to antibiotics rather than more resistant,” the authors said.
Related Articles on Antibiotic-Resistant Bacteria:
Two California Hospitals Report C. Diff Outbreaks
LifeSpan Study Shows Molecular Technology Best at Detecting C. Diff Infections
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
